Literature DB >> 10881023

Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker.

N Rubio1, M M Villacampa, N El Hilali, J Blanco.   

Abstract

BACKGROUND: Sensitive procedures for quantitative measurement of tumor cell spread as a function of time and primary tumor size are necessary to generate models of metastasis and formulate therapies.
METHODS: Prostate carcinoma cells PC-3.luc expressing the luciferase gene were intramuscularly inoculated in nude mice to generate experimental tumors. Metastatic cells in target organs were easily counted by their capacity to produce light.
RESULTS: Tumor cells were very mobile and migrated to all the target organs examined: lymph nodes, brain, bone, lungs, liver, kidney, spleen, testicles, prostate, seminal vesicle, and scrotum. Organ colonization started very early, 14 days after inoculation, when primary tumors were very small and produced an amount of light equivalent to that generated by 2 x 10(4) tumor cells in vitro (tumor cell equivalents, TCEs). Tumor cell burden could be quantitatively described by power functions of time or primary tumor light-producing capacity. The ratio of metastatic TCEs to primary tumor TCEs clustered around organ characteristic values: 10(-3) for femur and lumbar lymph nodes, 10(-6) for the spleen, and 10(-3) for the added set of organs.
CONCLUSIONS: Dispersal of PC-3 tumor cells from IM experimental tumors started early before the third week postinoculation and when primary tumors had 2 x 10(4) TCEs. Tumor cells were found widely spread in all the organs tested. The possibility of easily quantifying tumor cell burden should make this approach useful for the study of metastasis and the development of antimetastatic therapies. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881023     DOI: 10.1002/1097-0045(20000701)44:2<133::aid-pros6>3.0.co;2-n

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.

Authors:  Jean-Sébastien Annicotte; Irena Iankova; Stéphanie Miard; Vanessa Fritz; David Sarruf; Anna Abella; Marie-Laurence Berthe; Danièle Noël; Arnaud Pillon; François Iborra; Pierre Dubus; Thierry Maudelonde; Stéphane Culine; Lluis Fajas
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

2.  JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.

Authors:  Anette Hübner; David J Mulholland; Claire L Standen; Maria Karasarides; Julie Cavanagh-Kyros; Tamera Barrett; Hongbo Chi; Dale L Greiner; Cathy Tournier; Charles L Sawyers; Richard A Flavell; Hong Wu; Roger J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

3.  Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.

Authors:  Lee Jia; Patricia E Noker; Gary A Piazza; Carola Leuschner; William Hansel; Gregory S Gorman; Lori U Coward; Joseph Tomaszewski
Journal:  J Pharm Pharmacol       Date:  2008-11       Impact factor: 3.765

4.  Glutaric acid as a spacer facilitates improved intracellular uptake of LHRH-SPION into human breast cancer cells.

Authors:  Challa S S R Kumar; Carola Leuschner; Michelle Urbina; Teyhida Ozkaya; Josef Hormes
Journal:  Int J Nanomedicine       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.